Compare FBRX & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRX | BYRN |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.4M | 365.2M |
| IPO Year | N/A | N/A |
| Metric | FBRX | BYRN |
|---|---|---|
| Price | $31.38 | $15.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $67.00 | $41.50 |
| AVG Volume (30 Days) | 176.8K | ★ 468.3K |
| Earning Date | 11-14-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 543.53 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $110,853,000.00 |
| Revenue This Year | N/A | $40.07 |
| Revenue Next Year | N/A | $20.31 |
| P/E Ratio | ★ N/A | $23.84 |
| Revenue Growth | N/A | ★ 50.99 |
| 52 Week Low | $4.90 | $13.68 |
| 52 Week High | $35.46 | $34.78 |
| Indicator | FBRX | BYRN |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 35.42 |
| Support Level | $29.79 | $15.35 |
| Resistance Level | $33.58 | $16.30 |
| Average True Range (ATR) | 3.49 | 0.80 |
| MACD | 0.13 | -0.13 |
| Stochastic Oscillator | 70.81 | 8.97 |
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.